Effect of Trypsin Inhibitors on Shwartzman Phenomenon.
- 1 December 1961
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 108 (3) , 587-591
- https://doi.org/10.3181/00379727-108-27004
Abstract
The conventional Shwartzman Phenomenon (SP) was produced in 160 rabbits by Escherichia coli endotoxin. Trypsin inhibitors administered intravenously at about the time of the provocative injection, partially or completely inhibited the SP. There was no effect when the inhibitors were administered mixed with the endotoxin skin preparatory dose, or intravenously at time of skin preparation. The results suggest that proteolytic enzymes are involved in the SP. These enzymes may produce tissue changes directly or through release of histamine, heparin, serotonin and/or activation of plasma kinins, factors which affect vascular tonicity, permeability, and the coagulation process.Keywords
This publication has 7 references indexed in Scilit:
- SOME EFFECTS OF PROTEOLYTIC INHIBITORS ON TISSUE INJURY AND SYSTEMIC ANAPHYLAXISThe Journal of Experimental Medicine, 1961
- Pyrogens as thrombolytic agentsThe American Journal of Cardiology, 1960
- Potentiation of the Local Shwartzman Phenomenon by Trypsin.Experimental Biology and Medicine, 1960
- ALTERATIONS IN THE BLOOD COAGULATION SYSTEM INDUCED BY BACTERIAL ENDOTOXINThe Journal of Experimental Medicine, 1958
- THE PREVENTION OF THE GENERALIZED SHWARTZMAN REACTION WITH SODIUM WARFARINThe Journal of Experimental Medicine, 1958
- STUDIES ON THE MECHANISM OF THE SHWARTZMAN PHENOMENONThe Journal of Experimental Medicine, 1951
- OBSERVATIONS ON THE RELEASE OF SERUM FIBRINOLYSIN BY SPECIFIC ANTIGEN, PEPTONE, AND CERTAIN POLYSACCHARIDESThe Journal of Experimental Medicine, 1949